Background and Aim: As placenta is a mirror image of fetal outcome. By Colour Doppler we visualise the fetoplacental blood flow in situ and study the changes in blood flow throughout the pregnancy. Nowadays, Hypertension is a common disorder in pregnancy. With the help of 2D sonography and Doppler study we can examine the placenta, umbilical artery and foetal middle cerebral artery flow to predict neonantal outcome. Materials and Methods: The purpose of present study was to co relate the foeto placental blood flow in normal and pregnancy induced hypertensive mothers. This study was conducted on total number of 120 patients after 28 weeks of pregnancy attending the Department of Obstetrics and Gynecology and radio diagnosis at Padmashri Dr. D. Y. Patil Hospital, Kolhapur, India. Detailed personal and family history was taken, general examination of the patient was done in normal and pregnancy induced hypertensive mothers. With the help of Doppler the flow of umbilical artery as well as fetal middle cerebral artery was studied. Chi-squre test and Unpaired t'test was carried out for statistical analysis. Result: Fetal outcome is found to be directly related to severity of maternal hypertension ischemic results in inadequate transfer of oxygen and nutrients to the fetus resulting in increased incidence of hypoxia, growth retardness and fetal loss. In hypertensive mothers, S/D ratio of fetoplacental flow in fetal Middle Cerebral Artery is reduced as compared to Normal pregnancy. Conclusion: Thus, we conclude that regular monitoring of placenta in antenatal care and Doppler velocimetry is primary tool for fetomaternal surveillance in hypertensive pregnancies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.